$ADVM Adverum Biotechnologies, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adverum Biotechnologies, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adverum Biotechnologies, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Adverum Biotechnologies, Inc. for free.
IRS Number: 205258327
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ADVM
Company Address: 800 SAGINAW DRIVE REDWOOD CITY 94063
Phone number: 650-272-6269
Former name: Avalanche Biotechnologies, Inc., date of change: 2010-09-21
Prev close: $0.00
Average Daily Volume: 328,335
Days Low: $0.00
Year Low: $3.89
Year High: $41.60
Adverum Biotechnologies, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14 2021 | ADVM | Adverum Biotechnol ... | Woiwode Thomas | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Whitcup Scott M | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Scopa James Paul | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Lupher, Jr. Mark L. | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Gasmi Mehdi | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 12,500 | 46,250 | 12,500 | |
| May 14 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Option Exercise | A | 3.70 | 40,000 | 148,000 | 40,000 | |
| Apr 01 2021 | ADVM | Adverum Biotechnol ... | Svoronos Dawn | Director | Buy | P | 10.02 | 20,000 | 200,338 | 20,000 | 0 to 20 K |
| Mar 24 2021 | ADVM | Adverum Biotechnol ... | Fischer Laurent | CEO and Director | Buy | P | 9.88 | 10,000 | 98,780 | 26,292 | 16.3 K to 26.3 K (+61.38 %) |
| Mar 24 2021 | ADVM | Adverum Biotechnol ... | Machado Patrick | Director | Buy | P | 9.92 | 10,000 | 99,196 | 88,182 | 78.2 K to 88.2 K (+12.79 %) |
| Feb 23 2021 | ADVM | Adverum Biotechnol ... | Tuckson Reed Vaughn | Director | Option Exercise | A | 12.85 | 45,000 | 578,250 | 45,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Thedinga Angela | Chief Technology Of ... | Option Exercise | A | 13.44 | 250,000 | 3,360,000 | 250,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Soparkar Peter | Chief Legal Officer | Option Exercise | A | 13.44 | 140,000 | 1,881,600 | 140,000 | |
| Feb 18 2021 | ADVM | Adverum Biotechnol ... | Osborne Aaron | Chief Medical Offic ... | Option Exercise | A | 13.44 | 150,000 | 2,016,000 | 150,000 |
View all Adverum Biotechnologies, Inc. insider transactions.